Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer

30 Nov 2021

Abstract excerpt

Background: This study aimed to investigate the TP53 mutation, its potential immune features, its prognostic value, and its impact on immune infiltration in patients with breast cancer (BC). Methods: We downloaded the somatic mutation data and clinicopathologic features of BC patients from the TCGA GDC database, UCSC Xena platform, and International Cancer Genome Consortium (ICGC) database. The association...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34917611
DOI: 10.3389/fcell.2021.759154

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast CancerPMID 34917611Read ↗

<i>TP53</i> mutations promote immunogenic activity in breast cancerSemantic proximity Read ↗

The Negative Correlation Between TNBC Mutation Frequency and Immune Function: Is Immune Involvement in Regulating Mutations?Semantic proximity Read ↗

The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients.Semantic proximity Read ↗

Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell TranscriptomesSemantic proximity Read ↗

Interleukin-17-based cytokine signaling as a determinant for tumor immune microenvironment with prognostic value in triple-negative breast cancerSemantic proximity Read ↗

A scoring screening system based on machine learning for immunotherapy beneficiaries in triple-negative breast cancerSemantic proximity Read ↗

A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutationSemantic proximity Read ↗

Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer.Semantic proximity Read ↗

P53 immunohistochemistry is an ideal surrogate marker for TP53 mutation and a predictor of early metastasis in breast cancer: Real-world analysisSemantic proximity Read ↗

Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate.Semantic proximity Read ↗

Establishment and validation of an immune infiltration predictive model for ovarian cancer.Semantic proximity Read ↗

New immunological potential markers for triple negative breast cancer: IL18R1, CD53, TRIM, Jaw1, LTB, PTPRCAPSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.